First-line FOLFOX therapy for advanced esophageal squamous cell carcinoma: Multicenter prospective study in Japan.

Authors

null

Kunihiro Fushiki

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Kunihiro Fushiki , Takahiro Tsushima , Yasuhiro Tsubosa , Akifumi Notsu , Shun Yamamoto , Izuma Nakayama , Hiroshi Imazeki , Yoichi Hamai , Masaaki Motoori , Motoo Nomura , Kohei Nakachi , Soichi Fumita , Satoshi Otsu , Yoshihiro Tanaka , Kentaro Murakami , Mitsuhiro Furuta , Hiroya Takeuchi , Ken Kato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Clinical Trial Registration Number

000044485

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 280)

DOI

10.1200/JCO.2024.42.3_suppl.280

Abstract #

280

Poster Bd #

C18

Abstract Disclosures